2012
DOI: 10.1158/1078-0432.ccr-11-1877
|View full text |Cite|
|
Sign up to set email alerts
|

Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy

Abstract: Purpose Bevacizumab, an anti-VEGFA antibody, inhibits the developing vasculature of tumours, but resistance is common. Antiangiogenic therapy induces hypoxia and we observed increased expression of hypoxia-regulated genes, including carbonic anhydrase IX (CAIX), in response to Bevacizumab treatment in xenografts. CAIX expression correlates with poor prognosis in most tumour types and with worse outcome in Bevacizumab-treated metastatic colorectal cancer patients, malignant astrocytoma and recurrent malignant g… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

15
236
1
4

Year Published

2014
2014
2019
2019

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 215 publications
(256 citation statements)
references
References 43 publications
(59 reference statements)
15
236
1
4
Order By: Relevance
“…Excessive extracellular acidification could become detrimental, but the extent of this may be curtailed by the inhibitory (i.e. negative feedback) effect of H þ ions on CA activity [33][34][35]. 2 and H þ -lactate diffusion away from the surface of cells is expected to produce a more alkaline pH i that better supports cell proliferation.…”
Section: Production and Venting Of Metabolic Acidsmentioning
confidence: 99%
“…Excessive extracellular acidification could become detrimental, but the extent of this may be curtailed by the inhibitory (i.e. negative feedback) effect of H þ ions on CA activity [33][34][35]. 2 and H þ -lactate diffusion away from the surface of cells is expected to produce a more alkaline pH i that better supports cell proliferation.…”
Section: Production and Venting Of Metabolic Acidsmentioning
confidence: 99%
“…It has been proposed that CAIX could serve as a specific biomarker for this kind of tumor. The necessity of CAIX for tumor and metastasis formation has also been recently demonstrated by using the knock-down approach 25 . Further, inhibition of CAIX has been shown to result in regression or growth inhibition of mouse and human breast tumors as well as inhibition of cancer metastasis formation 25 .…”
Section: Discussionmentioning
confidence: 98%
“…As mentioned above all hypoxic tumors overexpressed CA IX and CA XII isoforms after activation of the hypoxia inducible factor-1 (HIF-1) 6 with a pH imbalance between the tumor tissue and the normal tissue as main consequence 6,8,14 . The hCA IX/XII isoforms inhibition with sulfonamides was recently shown to reverse the effect of tumor acidification 6,8,14 , leading to inhibition of the primary tumor and metastases growth, and CA IX/XII have been proposed as novel therapeutic antitumor targets 1,13 .…”
Section: Chemistrymentioning
confidence: 99%
“…The hCA IX/XII isoforms inhibition with sulfonamides was recently shown to reverse the effect of tumor acidification 6,8,14 , leading to inhibition of the primary tumor and metastases growth, and CA IX/XII have been proposed as novel therapeutic antitumor targets 1,13 . Reported here, there are novel ureido-benzenesulfonamide CAIs obtained considering compounds A-D as leads, some of which incorporate the same R-ureido linker, where R was phenyl, benzyl, cyclopentyl and 4-iodophenyl 21 together with a GABA portion connecting the 4-aminomethyl or 4-aminoethylbenzene sulfonamide and the ureido moieties.…”
Section: Chemistrymentioning
confidence: 99%
See 1 more Smart Citation